Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 1 23Phase 3 13Phase 1/2 10Phase NA 6Phase EARLY_PHASE1 3Phase 2/3 1

Status

Completed 12Active not recruiting 6Recruiting 5Withdrawn 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2CNS 2Dermatologic 1

Conditions

Optic Nerve Glioma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Glioma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 5pembrolizumab 4Biopsy 4durvalumab 3atezolizumab 3Radiotherapy 3Radiosurgery 3Cyclophosphamide 3Bevacizumab 3palbociclib 2niraparib 2abemaciclib 2Trastuzumab 2Temozolomide 2Taxes 2Surgical Procedures, Operative 2Specimen Handling 2Melphalan 2Letrozole 2Ketamine 2Irinotecan 2Hydrocortisone 2Gemcitabine 2Ferrosoferric Oxide 2Dexamethasone 2Curcumin 2Blood Specimen Collection 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Radiotherapy × Clear all
NCT03235869 2018-03-15

Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Withdrawn
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02976441 2017-02-20

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Washington University School of Medicine

Phase EARLY_PHASE1 Withdrawn
CNS

Astrocytoma, Ependymoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡